Europe excels in fundamental research, yet too few discoveries reach the market. Many promising projects stall in the “Valley of Death,” where resources, incentives, and support for technology maturation are limited. While spin-offs attract significant attention, they are not always the right path, especially within Europe’s fragmented and under-resourced innovation landscape.
This webinar series showcases practical private, public, and hybrid models that help biomedical projects overcome these hurdles and move more effectively toward commercialisation.
In the fourth session of our series, Industry open innovation programs for collaboration with academia, Jiri Keirsse, Head of Innovation Strategy & Public Private Partnerships, and Toshal Patel, Head of Scouting and Partnering, from UCB will discuss the opportunities and challenges for academia-industry co-development in Europe, with a focus on the role of KTOs and the expectations from industry on that process.
This webinar is organised by the BioMedical SIG and supported by UCB. Join the BioMedical SIG to stay informed.
Most experienced technology transfer crew in the Europe.
Krzysztof Maternicki
Jan Dlugosz University, Poland
Recent studies on both sides of the Atlantic, directed by either ASTP or AUTM, demonstrate the tremendous economic and societal benefit and value technology transfer has brought us.
Koenraad Debackere
KU Leuven, Belgium
ASTP has attained a unique position that has turned it into a highly valued player on the global technology transfer scene.
Koenraad Debackere
KU Leuven, Belgium
A must-do for any staff involved in technology transfer and start-up creation.
Frederic Ratel
Institute of Chemical Research of Catalonia, Spain
There was ample opportunity to learn from colleagues through the workshop sessions or more formally through speakers either sharing their years of experience or their state of the art research. Well worth attending.
John Gleeson
University of Limerick, Ireland
Join our newsletter and get the latest news